Inhibition of pyroptosis components caspase-1, inflammasomes and gasdermin has been proved to confer protection in cerebral ischemia [11], AD [12], PD [48], developmental white matter injury [49] and EAE [10]. The gene discussed is CASP1; the disease is Parkinson disease.